StockpollyBeta
Get App
Popularity #3,347
DBVT · NASDAQ · Biotechnology

DBV Technologies (ADR) (DBVT)

Develops an investigational skin patch for peanut allergy using epicutaneous immunotherapy.

$12.20
vs last close+0.10 (+0.83%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue091011000000
Cost of revenue000400054000
Gross profit091−4110−5−4000
202130313124273833454851
Research & development161321242419213227333331
486765486111320
Selling & marketing0100000−10006
General & administrative076765496111315
Other expenses0020201−10110
Operating income−21−12−29−35−30−24−27−43−37−45−48−51
311101−1−11110
Interest income211101001110
Interest expense000000010000
Other non-operating income−300−10000−1000
Income before tax−18−11−27−34−30−23−28−44−36−44−47−51
Income tax expense−100−100−1−1−300−1
Net income from continuing operations−17−11−27−33−30−23−27−42−33−45−48−50
Net income−17−11−27−33−30−23−27−42−33−45−48−50
EPS, basic−$0.17−$0.12−$0.28−$0.34−$0.32−$0.24−$0.28−$0.44−$0.34−$0.60−$0.55−$0.49
EPS, diluted−$0.17−$0.12−$0.28−$0.34−$0.32−$0.24−$0.28−$0.44−$0.34−$0.60−$0.55−$0.49
Weighted average shares, basic969698969696969696778686
Weighted average shares, diluted989698969696969696778686
EBITDA−17−9−26−30−29−23−25−38−31−44−46−51
Depreciation & amortization032421254120
EBIT−18−12−29−34−30−24−27−43−36−45−48−51